Director Joerg Neermann Receives Stock Options in Immunic, Inc.

This Form 4 filing reports that Joerg Neermann, a director of Immunic, Inc. (IMUX), received 25,370 stock options on July 5, 2026. The options have an exercise price of $14.80 per share and expire on July 5, 2036. The options will vest in monthly increments over a one-year period from the grant date. Following this transaction, Neermann now holds 25,370 stock options. As a director, Neermann is required to report these transactions under Section 16 of the Securities Exchange Act. The filing was signed on July 7, 2026, and the transaction was reported as an acquisition (code A) of derivative securities.